Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism

被引:48
作者
Beeton, Michael L. [1 ]
Chalker, Victoria J. [2 ]
Kotecha, Sailesh [1 ]
Spiller, O. Brad [1 ]
机构
[1] Cardiff Univ, Univ Wales Hosp, Sch Med, Dept Child Hlth, Cardiff CF14 4XN, S Glam, Wales
[2] Hlth Protect Agcy Ctr Infect, Resp & Syst Infect Lab, London NW9 5EQ, England
关键词
genetic polymorphisms; ciprofloxacin; DNA gyrase; topoisomerase IV; MYCOPLASMA-HOMINIS; IDENTIFICATION; MECHANISMS;
D O I
10.1093/jac/dkp218
中图分类号
R51 [传染病];
学科分类号
100201 [内科学];
摘要
Objectives: To determine the role of amino acid substitutions in Ureaplasma GyrA, GyrB, ParC and ParE proteins in mediating fluoroquinolone resistance. Methods: Nucleic acid sequences from gyrA, gyrB, parC and parE genes from all 14 Ureaplasma serovars were aligned. Full genome sequences for serovars 1, 3-7, 9 and 11-14 were available from the National Center for Biotechnology Information database and we sequenced the full topoisomerase genes from ciprofloxacin-susceptible reference strains of serovars 2, 8 and 10. Phylogenetic trees were constructed to analyse nucleotide sequence similarity. Deduced amino acid sequences were compared with all 33 previously reported fluoroquinolone-resistant strains to clarify true fluoroquinolone-resistance-associated substitutions. Results: Non-resistance-associated polymorphisms were identified in GyrA (39), GyrB (26), ParC (107) and ParE (34) proteins. Phylogenetic analysis demonstrated species clustering for all genes, except parE in which serovars 4, 12, 10 and 13 formed a separate cluster more similar to Ureaplasma parvum than the remaining Ureaplasma urealyticum serovars. Examination of all previously reported fluoroquinolone-resistant strains found that one-third of identified residue substitutions could be attributed to normal species polymorphism; therefore, the mechanism of resistance for these strains is still undetermined. In particular, Glu or Asp at position 112 in GyrA and Ala or Thr at 125/136 in ParC were substitutions identified when U. urealyticum strain sequences were previously aligned with the published serovar 3 genome sequence. Conclusion: Combining analysis of the recently available Ureaplasma genomes with sequences from the additional serovars has enabled us to clarify which substitutions found by previous investigators could potentially be responsible for fluoroquinolone resistance.
引用
收藏
页码:529 / 538
页数:10
相关论文
共 15 条
[1]
In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized [J].
Bebear, CM ;
Renaudin, H ;
Charron, A ;
Gruson, D ;
Lefrancois, M ;
Bebear, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) :2557-2560
[2]
DNA gyrase and topoisomerase IV mutations in clinical isolates of Ureaplasma spp. and Mycoplasma hominis resistant to fluoroquinolones [J].
Bébéar, CM ;
Renaudin, H ;
Charron, A ;
Clerc, M ;
Pereyre, S ;
Bébéar, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (10) :3323-3325
[3]
Concurrent Titration and Determination of Antibiotic Resistance in Ureaplasma Species with Identification of Novel Point Mutations in Genes Associated with Resistance [J].
Beeton, Michael L. ;
Chalker, Victoria J. ;
Maxwell, Nicola C. ;
Kotecha, Sailesh ;
Spiller, O. Brad .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (05) :2020-2027
[4]
Fluoroquinolone resistance in Ureaplasma parvum in the United States [J].
Duffy, L ;
Glass, J ;
Hall, G ;
Avery, R ;
Rackley, R ;
Peterson, S ;
Waites, K .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (04) :1590-1591
[5]
Ureaplasma urealyticum meningitis in an adult patient [J].
Geissdoerfer, Walter ;
Sandner, Guenter ;
John, Stefan ;
Gessner, Andre ;
Schoerner, Christoph ;
Schroeppel, Klaus .
JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (03) :1141-1143
[6]
The complete sequence of the mucosal pathogen Ureaplasma urealyticum [J].
Glass, JI ;
Lefkowitz, EJ ;
Glass, JS ;
Heiner, CR ;
Chen, EY ;
Cassell, GH .
NATURE, 2000, 407 (6805) :757-762
[7]
Mechanisms of fluoroquinolone resistance [J].
Hooper, DC .
DRUG RESISTANCE UPDATES, 1999, 2 (01) :38-55
[8]
Mechanisms of fluoroquinolone resistance: An update 1994-1998 [J].
Piddock, LJV .
DRUGS, 1999, 58 (Suppl 2) :11-18
[9]
DISSEMINATION OF THE TETM TETRACYCLINE RESISTANCE DETERMINANT TO UREAPLASMA-UREALYTICUM [J].
ROBERTS, MC ;
KENNY, GE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (02) :350-352
[10]
Proposal of Ureaplasma parvum sp nov and emended description of Ureaplasma urealyticum (Shepard et al. 1974) Robertson et al. 2001 [J].
Robertson, JA ;
Stemke, GW ;
Davis, JW ;
Harasawa, R ;
Thirkell, D ;
Kong, FR ;
Shepard, MC ;
Ford, DK .
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, 2002, 52 :587-597